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ndra M. Popescu, MD, William S. Weintraub, MD
ewark, Delaware
remendous improvements in interventional cardiology
ake percutaneous coronary intervention (PCI) a rather
outine procedure, at least in the U.S. and other wealthy
ountries around the world. Approximately 1 million PCIs
re performed annually in the U.S., with health care costs
pproaching $10 billion. Reducing costs of expensive, fre-
uently performed procedures is a societal imperative. Ag-
ng baby boomers, increasing demand on hospital services,
nd rising costs of health care call for strategies to decrease
xpenditures. Such strategies, although increasingly popu-
ar, must be carefully examined, because cutting cost must
e safe while providing financial benefit to both payers and
ealth care providers.
See page 1011
The cost analysis published by Rinfret et al. (1) in this
ssue of JACC: Cardiovascular Interventions aims to charac-
erize the economic impact of same-day discharge after
ncomplicated transradial PCI. In the clinical outcome
eport from the EASY (EArly Discharge After Transradial
tenting of CoronarY Arteries) trial (2), a total of 1,004
atients were randomized after uncomplicated PCI to either
ame-day discharge or overnight hospital stay. Those who
tayed overnight received a 12-h infusion of abciximab,
hereas the early discharge group had solely abciximab
olus during intervention. There was no difference at 30
ays after PCI in the primary composite end point (death
rom any cause, unplanned revascularization, myocardial
nfarction [MI], major bleeding, access site complications,
epeat hospital stay related to PCI, severe thrombocytope-
ia). There was, however, a statistically significant increase
n repeat revascularization in the early discharge group (5 in
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.t
From the Christiana Care Hospital, Newark, Delaware. The authors have reported
hat they have no relationships to disclose.he early discharge group vs. 0 in the overnight group, p 
.025). In this cost analysis Rinfret et al. (1) estimated
0-day post-PCI health care cost in Canadian dollars and
ctual post-PCI hospital cost/patient involved in the EASY
rial. Savings associated with same-day discharge were
ignificant ($1,117 1,554 for outpatient PCI vs. $2,258
,328 for overnight-stay). The mean difference of $1,141
95% confidence interval: $962 to $1,320), representing a
0% relative reduction in medical costs after PCI, was
ainly attributed to the hospital cost for the overnight stay
procedure cost was the same for both groups and not
alculated in this analysis). These findings, although ex-
remely enticing, must be considered critically. One poten-
ial limitation of the current analysis is that it did not use
ctual costs for patients enrolled in the EASY trial but
ather estimates based on charges from a different hospital.
lthough it did not use the actual cost for each individual
atient, it seems reasonable to extrapolate costs incurred
ithin the same health system. In addition, sensitivity
nalysis confirmed that by decreasing or increasing the
er-hour cost from $65/h/patient used for analysis to as low
s $10 or as high as $88 or $167/h/patient, the cost saving
emained significant for the outpatient group. The 30-day
ollow-up was critical, because this analysis demonstrated
hat there were no increased costs after discharge in the early
ischarge group, although there was an increase in repeat
ngiography (10 patients in the early discharge group vs. 7
atients in the inpatient group) and increase in subsequent
evascularization (5 patients in the early discharge group vs.
one in the inpatient group, p  0.025).
At least 2 critical questions are raised concerning dis-
harging patients on the same day after PCI: the first is
hether it is safe, and the second is whether it saves money
nd for whom. Among the first to publish their data, Koch
t al. (3–5) proved that patients can be safely triaged to
ame-day discharge or overnight stay on the basis of
ndependent predictors, such as acute closure, side branch
cclusion, unsuccessful PCI, female sex, and unplanned
tent. The randomized EPOS trial (Elective PCI in Out-
atient Study) published by Heyde et al. (6) in 2007 also
emonstrated safety of same-day discharge in selected
atients, with 1-year outcome data similar in the 2 groups.
he major limitation of these non-U.S. studies is that
nticoagulation and antiplatelet therapies were limited to
eparin and clopidogrel. Newer agents, such as glycoprotein
Ib/IIIa or direct thrombin inhibitors, widely used in the
.S., were excluded from these studies. Nonrandomized
tudies including newer agents had small sample size and
ence limited power (7). Another limitation of most of
hese non-U.S. studies is transradial vascular access (8–11),
arely used in the U.S. but widely used in Europe with
ignificantly less bleeding risk. Findings of these studies are
hus somewhat less pertinent to the current U.S. practice.
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1021The second question raised by the current cost analysis
onducted by Rinfret et al. (1) is whether the savings seen in
he Canadian health system are truly applicable to U.S.
ealth care. Although it might seem very attractive to the
ealth care system, there might be actually a disincentive for
ospitals to move from an inpatient reimbursement to an
utpatient same-day discharge reimbursement.
In our hospital, most elective PCIs are reimbursed as
utpatient procedures (23-h observation with overnight stay
fter procedure), considerably less than inpatient PCI (av-
rage $7,000 for outpatient PCI vs. $9,000 for inpatient
CI). A significant number of nonelective PCI patients
currently reimbursed as inpatient PCI) could be safely
ischarged the same day after PCI, according to EASY trial
ndings. At our hospital, the marginal cost for 1-night
bservation stay is approximately $400, considerably less
han the average $1,140 used by Rinfret et al. (1) in their
nalysis. If one-half of the almost 1 million PCIs performed
nnually in U.S. were eligible for same-day discharge
elective PCIs and uncomplicated PCIs in low-risk patients
ith unstable angina or non–ST-segment elevation MI),
ealth care savings would be between $200 million and
500 million (using marginal cost for overnight observation
t our institution vs. average cost for overnight stay in
anada). If the current outpatient PCI reimbursement
emains the same, hospitals save at least $200 million by
ischarging patients the same day. Health system savings
an potentially be higher if low-risk patients with unstable
ngina and non–ST-segment elevation MI (currently reim-
ursed at inpatient level) are discharged the same day and
CI is reimbursed at outpatient level. In addition, an
ncrease in inpatient capacity (potentially 500,000 bed-
ights/year) might reflect an increase in hospital revenues.
lthough this extrapolation from a single center has its
bvious limitations, the potential savings must be consid-
red in an era with limited health care resources.
At least 2 other barriers must be addressed to implement
ame-day PCI as a new standard of care in the U.S. The first
arrier is the medicolegal risk that U.S. providers and hospitals
ight incur by adopting a strategy different from the current
tandard of care. This is of less concern in the countries where
ost studies were performed. The second challenge is the
ikely apprehension of the U.S. public in considering a same-
ay discharge approach as a safe and preferred strategy. Newly
iagnosed cardiovascular disease is a burden for patients, and
hey might benefit from additional in-hospital targeted educa-
ion while staying overnight.
Current cost analysis by Rinfret et al. (1) demonstrates a
ecrease in health care costs with same-day discharge. datient safety, however, must come first. We believe that
arger studies reflecting the accepted U.S. practice (trans-
emoral access and new pharmacological agents [i.e., direct
hrombin or glycoprotein IIb/IIIa inhibitors]) or a U.S.
tudy using transradial approach ought to be available before
aking major changes in standard of care by discharging
ow-risk patients on the same day after PCI. Decreased
ayment by insurers might represent an incentive for U.S.
ospitals to participate in safety trials on same-day discharge
fter uncomplicated PCI.
eprint requests and correspondence: Dr. Andra M. Popescu,
hristiana Care Hospital, Cardiology, 4755 Ogletown-Stanton
oad, Room 2E99, Newark, Delaware 19718. E-mail: apopescu@
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